OWCP has nothing of value for Bayer etc. It is similar to the nonsense about Teva acquiring the OWCP patents - the only problem was that OWCP doesn't own any patents.
OWCP doesn't have any assets - they don't have any revenue - all they have are press releases and 8-Ks.
Why don't you post what OWCP has that Bayer or Foamix would be interested in doing a JV?
Is it the market ready psoriasis cream that doesn't have a safety study that hasn't been completed or even started. Then there is the missing efficacy report.
So Hirsch has shown he is just another OTCM pumping doorknob - that didn't write or understand the letter to the shareholders.
Maybe Hirsch doesn't understand the meaning of market ready.